Title: Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America20151115
Title: Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
Journal: Pharmacotherapy20151101
Title: Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.
Journal: Journal of clinical microbiology20130901
Title: Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections.
Journal: Expert opinion on drug metabolism & toxicology20120601
Title: Simultaneous determination of the azoles voriconazole, posaconazole, isavuconazole, itraconazole and its metabolite hydroxy-itraconazole in human plasma by reversed phase ultra-performance liquid chromatography with ultraviolet detection.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20120301
Title: Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
Journal: The Journal of antimicrobial chemotherapy20120201
Title: Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.
Journal: Infection and drug resistance20120101
Title: Resistance of Asian Cryptococcus neoformans serotype A is confined to few microsatellite genotypes.
Journal: PloS one20120101
Title: In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Journal: Diagnostic microbiology and infectious disease20111201
Title: Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist.
Journal: Medical mycology20111101
Title: In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.
Journal: Mycoses20110901
Title: Newer antifungal agents.
Journal: Expert review of anti-infective therapy20110301
Title: Antifungal activity of redox-active benzaldehydes that target cellular antioxidation.
Journal: Annals of clinical microbiology and antimicrobials20110101
Title: Epidemiology and treatment approaches in management of invasive fungal infections.
Journal: Clinical epidemiology20110101
Title: In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
Journal: Antimicrobial agents and chemotherapy20101201
Title: Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, Spain.
Journal: Medical mycology20101101
Title: Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
Journal: Mycopathologia20101101
Title: In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan.
Journal: International journal of antimicrobial agents20101001
Title: Chromatographic and electrophoretic techniques used in the analysis of triazole antifungal agents-a review.
Journal: Talanta20100915
Title: In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens.
Journal: Antimicrobial agents and chemotherapy20100901
Title: Opportunistic fungi: a view to the future.
Journal: The American journal of the medical sciences20100901
Title: Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis.
Journal: Medical mycology20100801
Title: [Recent advances in the study of new antifungal lead compounds].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica20100801
Title: In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Journal: Antimicrobial agents and chemotherapy20100401
Title: Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.
Journal: Current opinion in investigational drugs (London, England : 2000)20100201
Title: Microsatellite typing and susceptibilities of serial Cryptococcus neoformans isolates from Cuban patients with recurrent cryptococcal meningitis.
Journal: BMC infectious diseases20100101
Title: Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections.
Journal: Drug, healthcare and patient safety20100101
Title: Comparison of adverse events between oral and intravenous formulations of antimicrobial agents: a systematic review of the evidence from randomized trials.
Journal: Pharmacoepidemiology and drug safety20091001
Title: New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Journal: Expert review of anti-infective therapy20091001
Title: New generation azole antifungals in clinical investigation.
Journal: Expert opinion on investigational drugs20090901
Title: In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
Journal: The Journal of antimicrobial chemotherapy20090701
Title: In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries.
Journal: Journal of chemotherapy (Florence, Italy)20090601
Title: In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
Journal: Medical mycology20090201
Title: Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
Journal: Antimicrobial agents and chemotherapy20090101
Title: Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
Journal: The Journal of antimicrobial chemotherapy20090101
Title: Cryptococcus gattii: An Emerging Cause of Fungal Disease in North America.
Journal: Interdisciplinary perspectives on infectious diseases20090101
Title: Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections.
Journal: Future microbiology20081201
Title: New and investigational triazole agents for the treatment of invasive fungal infections.
Journal: Journal of chemotherapy (Florence, Italy)20081201
Title: Investigational antimicrobial drugs for bloodstream infections.
Journal: Current opinion in investigational drugs (London, England : 2000)20080801
Title: New and emerging treatments for fungal infections.
Journal: The Journal of antimicrobial chemotherapy20080101
Title: Drug evaluation: BAL-8557--a novel broad-spectrum triazole antifungal.
Journal: Current opinion in investigational drugs (London, England : 2000)20060801
Title: In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp.
Journal: The Journal of antimicrobial chemotherapy20060101
Title: Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers.
Journal: Antimicrobial agents and chemotherapy20060101
Title: Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteers.
Journal: Antimicrobial agents and chemotherapy20060101
Title: Seifert H, et al. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates. Antimicrob Agents Chemother. 2007 May;51(5):1818-21.
Title: Steinmann J, et al. In Vitro Activity of Isavuconazole against Rasamsonia Species. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6890-6891.
Title: Donnelley MA, et al. Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections. Infect Drug Resist. 2016 Jun 2;9:79-86.
Title: Box H, et al. Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis. Antimicrob Agents Chemother. 2015 Oct 26;60(1):278-87.
Title: Livermore J, et al. Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections. Expert Opin Drug Metab Toxicol. 2012 Jun;8(6):759-65.
